Sector pending / Surgical and Medical Instruments and ApparatusUpdated 2026-05-10 22:07 UTC

FRA/IC7 stock hub

FRA/IC7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/IC7is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/IC7

In the news

Latest news · FRA/IC7

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15

P25 n/aP50 n/aP75 n/a

Trailing P/E66.8

P25 n/aP50 n/aP75 n/a

ROE2.3

P25 n/aP50 n/aP75 n/a

ROIC3.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/IC7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	13,000
Employees Change	1,000%
Employees Change Percent	7.14
Enterprise value	EUR 3.5B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Surgical and Medical Instruments and Apparatus
Last refreshed	2026-05-10
Market cap	EUR 2.7B
Price	EUR 107
Price currency	EUR
Rev Per Employee	143,890.74x
Sic	3841
Symbol	fra/IC7
Website	https://www.icumed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.5%
EV Earnings	87.77x
EV/EBIT	38.33x
EV/EBITDA	12.66x
EV/FCF	49.18x
EV/Sales	1.93x
FCF yield	2.67%
Forward P/E	14.99x
P/B ratio	1.47x
P/E ratio	66.8x
P/S ratio	1.44x
PE Ratio10 Y	273.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.11%
EBITDA Margin	14.44%
FCF margin	3.83%
Gross margin	37.93%
Gross Profit	EUR 709.6M
Gross Profit Growth	-3.71%
Gross Profit Growth Q	-1.85%
Gross Profit Growth3 Y	4.31%
Gross Profit Growth5 Y	12.56%
Net Income	EUR 40.2M
Net Income Growth5 Y	-13.15%
Pretax Margin	0.44%
Profit Margin	2.15%
Profit Per Employee	EUR 3,092
ROA	1.68
Roa5y	1.71
ROCE	3.15
ROE	2.26
Roe5y	-0.9
ROIC	3.51
Roic5y	3.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.95%
Cagr15y	8.9%
Cagr1y	-9.33%
Cagr3y	-13.79%
Cagr5y	-9.16%
EPS Growth5 Y	-15.62
FCF Growth	-37.1%
FCF Growth Q	-24.79%
FCF Growth5 Y	-11.69%
OCF Growth	-20.11%
OCF Growth Q	-24.19%
OCF Growth10 Y	9.39%
OCF Growth5 Y	-6.52%
Revenue Growth	-10.88x
Revenue Growth Q	-12.32x
Revenue Growth3 Y	-2.2x
Revenue Growth5 Y	11.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.53
Assets	EUR 3.5B
Cash	EUR 250.1M
Current Assets	EUR 1B
Current Liabilities	EUR 439.2M
Debt	EUR 1.1B
Debt EBITDA	EUR 3.88
Debt Equity	EUR 0.61
Debt FCF	EUR 15.48
Equity	EUR 1.8B
Interest Coverage	1.25
Liabilities	EUR 1.6B
Long Term Assets	EUR 2.5B
Long Term Liabilities	EUR 1.2B
Net Cash	EUR -860.6M
Net Cash By Market Cap	EUR -32.06
Net Debt EBITDA	EUR 3.19
Net Debt Equity	EUR 0.47
Net Debt FCF	EUR 12
Tangible Book Value	EUR 23.8M
Tangible Book Value Per Share	EUR 0.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.34
Inventory Turnover	2.24
Net Working Capital	EUR 369.3M
Quick ratio	0.94
Working Capital	EUR 603.1M
Working Capital Turnover	EUR 2.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	21.24%
1Y total return	-9.32%
200-day SMA	113.9
3Y total return	-35.93%
50-day SMA	110
50-day SMA vs 200-day SMA	50under200
5Y total return	-38.15%
All Time High	272.5
All Time High Change	-60.74%
All Time High Date	2018-08-10
All Time Low	25.3
All Time Low Change	322.92%
All Time Low Date	2011-09-29
ATR	3.37
Ch YTD	-13.71
High	108
High52	136
High52 Date	2026-01-22
High52ch	-21.32%
Low	104
Low52	92
Low52 Date	2025-08-12
Low52ch	16.3%
Ma50ch	-2.7%
Price vs 200-day SMA	-6.04%
RSI	50.36
RSI Monthly	43.13
RSI Weekly	41.69
Sharpe ratio	-0.53x
Sortino ratio	-0.57
Total Return	-2.44%
Tr YTD	-13.71
Tr15y	259.24%
Tr1m	3.88%
Tr1w	5.94%
Tr3m	-17.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 95.5M
Operating Income Growth	-9.17
Operating Income Growth Q	2.69
Operating Income Growth3 Y	65.27
Operating Income Growth5 Y	-2.63
Operating margin	5.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24,508,207%
Net Borrowing	-221,956,597.4
Shares Insiders	1.91%
Shares Institutions	104.96%
Shares Qo Q	2.01%
Shares Yo Y	2.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 21.8M
Average Volume	0x
Bv Per Share	73.29
CAPEX	EUR -73.5M
Ch10y	21.24
Ch15y	259.2
Ch1m	3.88
Ch1w	5.94
Ch1y	-9.32
Ch3m	-17.69
Ch3y	-35.93
Ch5y	-38.15
Ch6m	-10.83
Change	2.88%
Change From Open	2.88
Close	104
Days Gap	0
Depreciation Amortization	170,714,253.7
Earnings Date	2026-05-07
EBIT	EUR 95.5M
EBITDA	EUR 270.1M
EPS	EUR 1.61
F Score	6
FCF	EUR 71.7M
FCF EV Yield	2.03x
Financing CF	-259,592,430
Fiscal Year End	December
Founded	1,984
Goodwill	1,259,699,276.7
Graham Number	51.29672
Graham Upside	-52.06
Income Tax	EUR -32M
Investing CF	110,867,826
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	EUR 8.01
Lynch Upside	-92.51
Ma150	116.3
Ma150ch	-7.96%
Ma20	105
Ma20ch	1.88%
Net CF	-1,191,670
Open	104
P FCF Ratio	37.43
P OCF Ratio	18.49
Position In Range	75
Ppne	420,527,250.8
Price Date	2026-05-08
Price EBITDA	EUR 9.94
Ptbv Ratio	113
Relative Volume	1,000x
Revenue	1,870,579,631x
SBC By Revenue	2.67x
Share Based Comp	49,947,807
Tax By Revenue	-1.71x
Tr6m	-10.83%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/IC7 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/IC7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/IC7?

Insider, institutional, and short-interest positioning.

Institutional ownership

+105.0%

Share of float held by funds and institutions

Insider ownership

+1.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.4%

Negative means the company is buying back shares.

Technical

FRA/IC7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.4

Neutral momentum band

Price vs 200-day MA

-6.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/IC7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/IC7 stock rating?

fra/IC7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/IC7 analysis?

The full report lives at /stocks/fra/IC7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/IC7?

The latest report frames fra/IC7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/IC7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.